Severe Hypoglycemia in Adults

Hypoglycemia is the most common endocrine emergency faced by practicing physicians, the most frequent complication of insulin-requiring diabetes, and the principal factor limiting optimization of glycemic control in diabetes. Hypoglycemia is defined arbitrarily as a blood glucose of less than 50 mg/dL (2.8 mmol/L) with neuroglycopenic symptoms or less than 40 mg/dL (2.2 mmol/L) in the absence of symptoms. Serious or severe hypoglycemia is usually defined as an episode where self-treatment is not possible, although the adjective “severe” is sometimes restricted to hypoglycemia which results in hospitalization, intravenous glucose or glucagon administration, seizure or coma. Severe hypoglycemia is a potentially lifethreatening crisis and the diagnosis of hypoglycemic coma should be considered in all unconscious patients. When severe hypoglycemia is not recognized and treated appropriately, significant morbidity including permanent neurological deficits and or death can result. Hypoglycemia in children is not discussed in this paper. The current review focuses on the frequency, pathophysiology, common causes, clinical presentation, diagnostic approach and management of severe hypoglycemia in adults.

[1]  F. Service,et al.  Diagnostic approach to adults with hypoglycemic disorders. , 1999, Endocrinology and metabolism clinics of North America.

[2]  I. Deary,et al.  Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes. , 2000, Diabetes care.

[3]  O. Søvik,et al.  Dead-in-bed syndrome in young diabetic patients. , 1999, Diabetes care.

[4]  R. Campbell Glimepiride: Role of a New Sulfonylurea in the Treatment of Type 2 Diabetes Mellitus , 1998, The Annals of pharmacotherapy.

[5]  R. Landgraf,et al.  A comparison of repaglinide and glibenclamide in the treatment of type 2 diabetic patients previously treated with sulphonylureas , 1999, European Journal of Clinical Pharmacology.

[6]  C. Binder,et al.  Symptomatic Hypoglycaemia in 411 Type 1 Diabetic Patients , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[7]  S. Hart,et al.  Causes, management and morbidity of acute hypoglycaemia in adults requiring hospital admission. , 1998, QJM : monthly journal of the Association of Physicians.

[8]  R O Potts,et al.  Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. , 1999, Diabetes care.

[9]  I J Deary,et al.  Severe Hypoglycemia and Intelligence in Adult Patients With Insulin-Treated Diabetes , 1993, Diabetes.

[10]  M. Palta,et al.  Risk factors for frequent and severe hypoglycemia in type 1 diabetes. , 2001, Diabetes care.

[11]  Douglas Borys,et al.  2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2004, The American journal of emergency medicine.

[12]  W. Berger,et al.  Higher incidence of severe hypoglycaemia leading to hospital admission in Type 2 diabetic patients treated with long‐acting versus short‐acting sulphonylureas , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[13]  T. Litovitz,et al.  1999 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 2000, The American journal of emergency medicine.

[14]  T. Litovitz,et al.  1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. , 1998, The American journal of emergency medicine.

[15]  T. Merimee,et al.  Stabilization of plasma glucose during fasting; Normal variations in two separate studies. , 1974, The New England journal of medicine.

[16]  F. Service Classification of hypoglycemic disorders. , 1999, Endocrinology and metabolism clinics of North America.

[17]  B. Frier,et al.  Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin , 2001, Diabetes/metabolism research and reviews.

[18]  I. Cranston,et al.  Altered Hierarchy of Protective Responses Against Severe Hypoglycemia in Normal Aging in Healthy Men , 1997, Diabetes Care.

[19]  B P Kovatchev,et al.  Progressive hypoglycemia's impact on driving simulation performance. Occurrence, awareness and correction. , 2000, Diabetes care.

[20]  V. Marks,et al.  Drug-induced hypoglycemia. , 1999, Endocrinology and metabolism clinics of North America.

[21]  M. Burge,et al.  A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus. , 1998, JAMA.

[22]  W. Ray,et al.  Antihypertensives and the Risk of Serious Hypoglycemia in Older Persons Using Insulin or Sulfonylureas , 1998 .

[23]  L. Jovanovic,et al.  Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. , 1999, JAMA.

[24]  P. Cryer,et al.  Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics. , 1988, The New England journal of medicine.

[25]  B. Frier,et al.  Frequency of Severe Hypoglycemia in Patients With Type I Diabetes With Impaired Awareness of Hypoglycemia , 1994, Diabetes Care.

[26]  T. Nick,et al.  The incidence of ethanol-induced hypoglycemia. , 1992, The American journal of emergency medicine.

[27]  B. Clarke,et al.  Comparison of Intravenous Glucagon and Dextrose in Treatment of Severe Hypoglycemia in an Accident and Emergency Department , 1987, Diabetes Care.

[28]  M. Huic,et al.  Adverse drug reactions resulting in hospital admission. , 1994, International journal of clinical pharmacology and therapeutics.

[29]  G V Gill,et al.  Unexplained Deaths of Type 1 Diabetic Patients , 1991, Diabetic medicine : a journal of the British Diabetic Association.

[30]  J. Levy,et al.  U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease , 1995, Diabetes.

[31]  J. Wahren,et al.  Brain substrate utilisation during acute hypoglycaemia , 1999, Diabetologia.

[32]  B. Frier,et al.  Frequency and Morbidity of Severe Hypoglycaemia in Insulin‐treated Diabetic Patients , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[33]  I. Deary,et al.  Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. , 1999, Diabetes care.

[34]  H. Shamoon,et al.  Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. , 1994, The American journal of medicine.

[35]  B. Frier,et al.  Frequency and Symptoms of Hypoglycaemia Experienced by Patients with Type 2 Diabetes Treated with Insulin , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[36]  T. Chalmers,et al.  Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes , 1993, The Lancet.

[37]  F. Nuttall,et al.  Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial , 1995, Diabetes Care.

[38]  K. Jungheim,et al.  Risky delay of hypoglycemia detection by glucose monitoring at the arm. , 2001, Diabetes care.

[39]  K. Ciechanowski,et al.  Chlorpropamide toxicity with survival despite 27-day hypoglycemia. , 1999, Journal of toxicology. Clinical toxicology.

[40]  I. Deary,et al.  Hypoglycemia and Cognitive Function , 1993, Diabetes Care.

[41]  B. Frier,et al.  Symptomatic and physiological responses to hypoglycaemia induced by human soluble insulin and the analogue Lispro human insulin , 1997, Diabetic Medicine.

[42]  A. Maran,et al.  Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes , 1994, The Lancet.

[43]  T. Noguchi,et al.  Evaluation of Death from Hypoglycemia , 1988, The American journal of forensic medicine and pathology.

[44]  M. Shichiri,et al.  Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. , 2000, Diabetes care.

[45]  P Wach,et al.  Validation of Home Blood Glucose Meters With Respect to Clinical and Analytical Approaches , 1998, Diabetes Care.

[46]  R. Rizza,et al.  Hormonal mechanisms in acute glucose counterregulation: the relative roles of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol. , 1980, Metabolism: clinical and experimental.

[47]  M. Stumvoll,et al.  Avoidance of Hypoglycemia Restores Hypoglycemia Awareness by Increasing -Adrenergic Sensitivity in Type 1 Diabetes , 2001, Annals of Internal Medicine.

[48]  W. Tamborlane,et al.  Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. , 1999, Diabetes care.

[49]  I. Mühlhauser,et al.  Intensified insulin therapy and the risk of severe hypoglycaemia , 1997, Diabetologia.

[50]  T. Koepsell,et al.  Increasing incidence of serious hypoglycemia in insulin users. , 2002, Journal of clinical epidemiology.

[51]  D. Schade,et al.  Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. , 1993, The Journal of clinical endocrinology and metabolism.

[52]  T. Jones,et al.  Decreased epinephrine responses to hypoglycemia during sleep. , 1998, The New England journal of medicine.

[53]  D. Klonoff,et al.  Hypoglycemia Following Inadvertent and Factitious Sulfonylurea Overdosages , 1995, Diabetes Care.

[54]  A. Terzic,et al.  Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. , 1999, The Journal of clinical endocrinology and metabolism.

[55]  C. D. Miller,et al.  Hypoglycemia in patients with type 2 diabetes mellitus. , 2001, Archives of internal medicine.

[56]  C. Airey,et al.  Hypoglycaemia induced by exogenous insulin –‘human’ and animal insulin compared , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[57]  M. Burge,et al.  Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms. , 2001, The Journal of clinical endocrinology and metabolism.

[58]  P. Boyle,et al.  Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.

[59]  P. Cryer,et al.  Reversibility of unawareness of hypoglycemia in patients with insulinomas. , 1993, The New England journal of medicine.

[60]  Thomas Waldhoer,et al.  Continuous subcutaneous insulin infusion in toddlers , 2003, European Journal of Pediatrics.